Ana Gabriela Claros

Dr. Ana Gabriela Claros

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LCLizeth León Carreño
Lizeth León Carreño
DRDaniel Andes Pardo Rodriguez
Daniel Andes Pardo Rodriguez
ARAndrea Del Pilar Hernández Rodriguez
Andrea Del Pilar Hernández Rodriguez
JRJuliana Ramírez-Prieto
Juliana Ramírez-Prieto
GLGabriela López-Molina
Gabriela López-Molina
AOAlejandro Ondo-Mendez
Alejandro Ondo-Mendez
Breast cancer (BC) is a neoplasm characterized by high heterogeneity and is influenced by intrinsic molecular subtypes and clinical stage, aspects that remain underexplored in the Colombian population. This study aimed to characterize metabolic alterations associated with subtypes and disease progression in a group of newly diagnosed, treatment-naive Colombian women using an untargeted metabolomics approach. To improve metabolite coverage, samples were analyzed using LC-QTOF-MS and GC-QTOF-MS, along with amino acid profiling. The Luminal B subtype exhibited elevated levels of long-chain acylcarnitines and higher free fatty acid concentrations than the other subtypes. It also presented elevated levels of carbohydrates and essential glycolytic intermediates, suggesting that this subtype may adopt a hybrid metabolic phenotype characterized by increased glycolytic flux as well as enhanced fatty acid catabolism. Tumor, Node, and Metastasis (TNM) staging analysis revealed progressive metabolic reprogramming of BC. In advanced stages, a sustained increase in phosphatidylcholines and a decrease in lysophosphatidylcholines were observed, reflecting lipid alterations associated with key roles in tumor progression. In early stages (I-II), plasma metabolites with high discriminatory power were identified, such as glutamic acid, ribose, and glycerol, which are associated with dysfunctions in energy and carbohydrate metabolism. These results highlight metabolomics as a promising tool for the early diagnosis, clinical follow-up, and molecular characterization of BC.

24 March 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
MZMisk Al Zahidy
Misk Al Zahidy
KMKerly Guevara Maldonado
Kerly Guevara Maldonado
LALuis Vilatuna Andrango
Luis Vilatuna Andrango
APAna Cristina Proano
Ana Cristina Proano
ACAna Gabriela Claros
Ana Gabriela Claros
JBJuan P Brito
Juan P Brito
Background: The promise of artificial intelligence (AI) in medicine depends on its ability to learn from data that reflect what matters to patients and clinicians in the care process. Most existing models are trained on electronic health records (EHRs), which primarily capture biological measures but rarely the interactions and relationships between patients and clinicians. These relationships, central to how care is understood, negotiated, and delivered, unfold across multiple modalities, including voice, text, and video, yet remain largely absent from current datasets. As a result, AI systems trained solely on EHRs risk perpetuating a narrow biomedical view of medicine and overlooking the lived exchanges that define clinical encounters. Objective: This study aims to design, implement, and evaluate the feasibility of a longitudinal, multimodal system for capturing patient-clinician encounters, linking 360° video or audio recordings with postvisit surveys and EHR data, to create a foundational dataset for downstream AI research. Methods: This single-site study was conducted in an academic outpatient specialty clinic (Division of Endocrinology, Mayo Clinic, Rochester, Minnesota, United States). Adult patients attending in-person visits with participating clinicians were invited to enroll. Encounters were recorded using a 360° 2D monocular video camera and dual-channel audio. After each visit, patients completed a brief survey assessing relational empathy, satisfaction, visit pace, and treatment burden. Demographic and clinical data were extracted from the EHR. Feasibility was assessed using 5 prespecified end points: clinician consent, patient consent, recording success, survey completion, and data linkage across modalities. Results: Recruitment began in January 2025. By August 2025, 35 of 36 (97%) eligible clinicians and 212 of 281 (75%) approached eligible patients had consented. Of the consented encounters, 162 (76%) resulted in a complete 360° video recording, and the postvisit surveys were completed for 204 of 212 (96%) consented encounters, reflecting 1 survey per encounter. Data collection is ongoing as of December 2025, and further analyses will be reported in subsequent publications. Conclusions: This protocol describes a longitudinal multimodal encounter capture system that links 360° audio or video with postvisit surveys and EHR data. The study specifies operational definitions, workflows, feasibility end points, and governance procedures to support implementation and replication in other clinical settings.

30 September 2026 in Thyroid®
Verified
Journal Article
Closed access
FLFelipe Larios
Felipe Larios
LALuis Vilatuna Andrango
Luis Vilatuna Andrango
MBMariana Borras-Osorio
Mariana Borras-Osorio
MBMegan E. Branda
Megan E. Branda
DTDavid Toro-Tobon
David Toro-Tobon
JBJuan P. Brito
Juan P. Brito
Background: Incidental thyroid nodules (ITNs) detected on nonthyroid imaging contribute to thyroid cancer overdiagnosis, largely through downstream evaluation initiated by thyroid ultrasound (TUS). However, TUS follow-up rates for ITNs and their drivers in routine practice remain unclear. We quantified TUS utilization after ITN detection and identified patient, imaging, nodule, and reporting factors associated with this first step in the diagnostic cascade. Methods: We conducted a retrospective cohort study of adults without prior thyroid disease who underwent imaging that incidentally captured the thyroid at Mayo Clinic sites (2017–2023). A validated natural language processing pipeline identified ITNs and extracted nodule characteristics from radiology reports across multiple imaging modalities. The main outcome was the rate of TUS within 180 days after ITN detection. Clinical outcomes, including thyroid biopsy, thyroidectomy, and thyroid cancer diagnosis, were compared between patients who underwent TUS and those who did not. Factors associated with TUS utilization were assessed using multivariable logistic regression with penalized variable selection. Results: Among 115,683 patients who underwent thyroid-capturing imaging, 8426 (7.3%) had an ITN. These patients were predominantly female (64.6%) and White (89.7%), with a mean age of 61.7 years (standard deviation 15.2). Most nodules were detected on computed tomography (80.8%), most commonly from chest imaging (52.3%). Overall, 1677 patients with ITNs (19.9%) underwent TUS. In multivariable analysis, TUS use was independently associated with higher body mass index (odds ratio [OR], 1.20 per 10-unit increase; confidence interval [CI] [1.08–1.33]), nodule size ≥1.5 cm (OR, 1.79; CI [1.52–2.10]), and a radiologist recommendation (OR, 2.51; CI [2.12–2.98]), whereas older age was associated with lower odds of TUS (OR, 0.89 per 10-year increase; CI [0.84–0.93]). Patients undergoing TUS had higher rates of thyroid biopsy, partial thyroidectomy, and total thyroidectomy compared with those without it. All detected thyroid cancers (103 cases) occurred in the TUS group, representing 6.1% of that cohort. Conclusions: One in five patients with ITNs underwent TUS, representing a critical gateway to downstream diagnostic procedures and thyroid cancer detection. Factors associated with TUS utilization highlight opportunities to better define appropriateness of ultrasound after incidental nodule detection and to reduce unnecessary testing and treatment.

28 June 2025 in Principles and Practice of Clinical Research Journal
Verified
Journal Article
Open access
PDF file
MSMaham Safarat
Maham Safarat
UMUniversidad Francisco Marroquin Guatemala Facultad de Medicina
Universidad Francisco Marroquin Guatemala Facultad de Medicina
CGCarlos Narvaez Gaitán
Carlos Narvaez Gaitán
ACAna Gabriela Claros
Ana Gabriela Claros
MPMaria-Antonia Pelaez
Maria-Antonia Pelaez
MUMiguel Urina-Triana
Miguel Urina-Triana
Introduction: Refractory angina pectoris poses a major public health challenge due to its effects on patients' quality of life, the significant healthcare costs involved, and its increasing prevalence among the aging population with coronary artery disease. This systematic review evaluates the efficacy of acupuncture as an adjunct therapy for this condition, particularly in reducing the frequency of angina attacks, the usage of nitroglycerin as a rescue medication, and pain intensity. Methods: The systematic review included randomized controlled trials (RCTs) published up to July 13, 2024, comparing any modality of acupuncture combined with conventional treatment versus conventional treatment alone, sham acupuncture, or non-meridian acupuncture. The inclusion criteria comprised adults diagnosed with stable angina pectoris for at least three months, experiencing angina more than once a week, and undergoing treatment for at least four weeks. Exclusions were applied for patients with severe cardiovascular or systemic conditions, pregnant or lactating women, and studies with incomplete data. Literature searches were conducted using PubMed, Cochrane Library, LILACS, Google Scholar, and Embase, with the risk of bias assessed via the Cochrane ROB2 tool. Results: Five RCTs involving participants of Chinese ethnicity were analyzed. Results indicated that acupuncture significantly reduced the frequency of angina attacks and improved the Seattle Angina Questionnaire scores and pain intensity as measured by the Visual Analogue Scale (VAS). Conclusion: Acupuncture could be effective as an adjunctive treatment for refractory angina pectoris. However, limitations due to sample size and generalizability necessitate further studies to corroborate these findings and assess long-term effectiveness.

20 April 2025 in Principles and Practice of Clinical Research Journal
Verified
Journal Article
Open access
PDF file
MKMaham Safarat Kirmani
Maham Safarat Kirmani
UMUniversidad Francisco Marroquín Facultad de Medicina
Universidad Francisco Marroquín Facultad de Medicina
CGCarlos Alberto Narvaez Gaitan
Carlos Alberto Narvaez Gaitan
MPMaria-Antonia Pelaez
Maria-Antonia Pelaez
ACAna Gabriela Claros
Ana Gabriela Claros
MUMiguel Alberto Urina-Triana
Miguel Alberto Urina-Triana
Introduction: This study examines whether recreational physical activity can reduce NSAID use among adults. While NSAIDs effectively manage pain, they carry risks like gastrointestinal and cardiovascular side effects. Exercise, known for its anti-inflammatory effects, offers a non-pharmacological alternative. Physical activity reduces inflammation through anti-inflammatory cytokines, and lower visceral fat, and immune support, suggesting it may reduce NSAID need. Methods: A cross-sectional analysis used 2017-2018 NHANES data, representing the U.S. population, including 5,145 adults with complete NSAID use and recreational physical activity data. Statistical analysis with STATA 18.5 applied univariate and logistic regression modeling to assess associations between recreational exercise (moderate, vigorous, or both) and NSAID use. Confounders, including age, gender, BMI, arthritis, and trouble sleeping, were adjusted in the final model. Key Findings: Participants engaging in both moderate and vigorous exercise had significantly lower odds of NSAID use (OR 0.50, 95% CI: 0.32, 0.78). Conversely, arthritis (OR 3.89, 95% CI: 2.83, 5.34) and at least one comorbidity (OR 1.75, 95% CI: 1.15, 2.65) were linked to higher NSAID use Implications and Conclusion: This study highlights regular moderate and vigorous exercise as a viable non-pharmacological strategy to reduce NSAID use and associated health risks. Recognizing factors like arthritis and sleep quality that influence NSAID use helps improve pain management strategies, with exercise as a beneficial addition. Further research should explore exercise types and lasting effects on NSAID reduction.

3 September 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MJMaria Lizarazo Jimenez
Maria Lizarazo Jimenez
ACAna Gabriela Claros
Ana Gabriela Claros
KGKieran Green
Kieran Green
DTDavid Toro-Tobon
David Toro-Tobon
FLFelipe Larios
Felipe Larios
OPOscar J Ponce-Ponte
Oscar J Ponce-Ponte
Background: Large language models (LLMs) are increasingly demonstrating the potential to reach human-level performance in generating clinical summaries from patient-clinician conversations. LLMs are usually evaluated against clinical summaries that focus mainly on patients’ biology and not on their biography (eg, preferences, values, wishes, and concerns). To achieve patient-centered care, artificial intelligence clinical summarization must incorporate patient-centered domains, implemented through patient-centered summaries (PCSs). Objective: This study aimed to develop a framework to generate PCS that capture patients’ values, preferences, and wishes while ensuring clinical utility for clinicians, and assess if current open-source LLMs can achieve human-level performance in generating PCS. Methods: We developed a 4-step mixed methods process to define and evaluate PCS. First, 2 patient and public involvement and engagement groups were convened in the United Kingdom (10 patients and 8 clinicians), who participated in semistructured interviews exploring what personal and contextual information should be included in clinical summaries and how it should be structured for clinical use. Second, findings were translated into an annotation guideline, which was used by 8 clinician annotators to generate gold standard PCS from 88 transcribed patient-clinician consultations about the management of atrial fibrillation. Third, 16 consultations were used to iteratively develop and refine a prompt aligned with the annotation guideline. Finally, 5 LLMs (Llama-3.2-3B [Meta AI], Llama-3.1-8B [Meta AI], Mistral-8B [Mistral AI], Gemma-3-4B [Google DeepMind], and Qwen3-8B [Alibaba]) generated summaries from 72 consultations using zero-shot and few-shot prompting, which were evaluated against gold standard PCS using ROUGE-L (Recall-Oriented Understudy for Gisting Evaluation–Longest Common Subsequence) and BERTScore (Bidirectional Encoder Representations from Transformers Score) and assessed for correctness, completeness, conciseness, patient-centeredness, and fluency. Results: Patients emphasized that summaries should include (1) lifestyle routines and daily functioning as indicators of independence or disruption; (2) the presence and role of social support systems, especially during crises; (3) recent life events or stressors, such as trauma, loss, or caregiving demands; and (4) care preferences, values, and communication styles that provide meaning or reflect autonomy. Clinicians sought summaries that included a concise functional baseline, psychosocial context, and emotional cues, preferably in a structured, clinically digestible format. In the 72 consultations (mean age 70, SD 11 y; 32/72, 44.4% female), the best zero-shot performance was observed with Mistral-8B (ROUGE-L 0.189) and Llama-3.1-8B (BERTScore 0.673). The best few-shot prompting was found with 3 examples using Llama-3.1-8B (ROUGE-L 0.206 and BERTScore 0.683). Conclusions: The open-source LLMs we evaluated did not achieve human-level performance in generating PCSs. Without task-specific fine-tuning, current open-source LLMs cannot reach human-level performance in this task. Our framework serves as an innovative guideline for developing gold standard PCS for artificial intelligence clinical tasks.